Peregrine Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $2.41M | Buy |
|
|||||
|
2022
Q4 | $2.41M | Sell |
|
|||||
|
2022
Q3 | $3.1M | Sell |
|
|||||
|
2022
Q2 | $3M | Sell |
|
|||||
|
2022
Q1 | $3.57M | Sell |
|
|||||
|
2021
Q4 | $3.47M | Buy |
|
|||||
|
2021
Q3 | $4.34M | Sell |
|
|||||
|
2021
Q2 | $9.93M | Sell |
|
|||||
|
2021
Q1 | $9.63M | Sell |
|
|||||
|
2020
Q4 | $13.1M | Sell |
|
|||||
|
2020
Q3 | $14.1M | Sell |
|
|||||
|
2020
Q2 | $11.2M | Buy |
|
|||||
|
2020
Q1 | $10.1M | Buy |
|
|||||
|
2019
Q4 | $12.7M | Sell |
|
|||||
|
2019
Q3 | $11.4M | Sell |
|
|||||
|
2019
Q2 | $12.8M | Sell |
|
|||||
|
2019
Q1 | $10.9M | Sell |
|
|||||
|
2018
Q4 | $12.8M | Sell |
|
|||||
|
2018
Q3 | $24M | Sell |
|
|||||
|
2018
Q2 | $27.3M | Sell |
|
|||||
|
2018
Q1 | $20.1M | Buy |
|
|||||
|
2017
Q4 | $17.5M | Buy |
|
|||||
|
2017
Q3 | $12.5M | Sell |
|
|||||
|
2017
Q2 | $14.6M | Sell |
|
|||||
|
2017
Q1 | $10.1M | Buy |
|
|||||
|
2016
Q4 | $8.85M | Buy |
|
|||||
|
2016
Q3 | $7.99M | Buy |
|